Cargando…

Anti−PD-1 Immunotherapy May Induce Interstitial Nephritis With Increased Tubular Epithelial Expression of PD-L1

INTRODUCTION: Novel anticancer therapies include anti–programmed cell death protein-1 (PD-1) and anti–programmed death ligand-1 (PD-L1) drugs. These novel medications have side effects in different organs, including the kidney. The most common adverse effect in the kidney is acute interstitial nephr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cassol, Clarissa, Satoskar, Anjali, Lozanski, Gerard, Rovin, Brad, Hebert, Lee, Nadasdy, Tibor, Brodsky, Sergey V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698303/ https://www.ncbi.nlm.nih.gov/pubmed/31440705 http://dx.doi.org/10.1016/j.ekir.2019.06.001

Ejemplares similares

IgA Staining Patterns Differentiate Between IgA Nephropathy and IgA-Dominant Infection-Associated Glomerulonephritis
por: Brodsky, Sergey V., et al.
Publicado: (2020)

Membranous Nephropathy With Crescents
por: Alawieh, Rasha, et al.
Publicado: (2020)

Anticoagulant-Related Nephropathy in Kidney Biopsy: A Single-Center Report of 41 Cases
por: Brodsky, Sergey V., et al.
Publicado: (2019)

Multivesicular bodies mimicking SARS-CoV-2 in patients without COVID-19
por: Calomeni, Edward, et al.
Publicado: (2020)

Kidney Biopsy Techniques to Differentiate Calcium Oxalate and Dihydroxyadenine Tubular Crystals
por: Ibrahim, Dalia, et al.
Publicado: (2022)

Membranoproliferative Glomerulonephritis With Changing Immunofluorescence Pattern
por: Satoskar, Anjali A., et al.
Publicado: (2022)

Clinical Outcomes in Patients With Biopsy Proven Anticoagulant-Related Nephropathy
por: Dasgupta, Alana, et al.
Publicado: (2023)

Acute kidney injury aggravated by treatment initiation with apixaban: Another twist of anticoagulant-related nephropathy
por: Brodsky, Sergey V., et al.
Publicado: (2017)

Establishing a Case for Anti-complement Therapy in Membranous Nephropathy
por: Ayoub, Isabelle, et al.
Publicado: (2020)

Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft
por: Von Visger, Jon, et al.
Publicado: (2019)

Rifampicin in Nontuberculous Mycobacterial Infections: Acute Kidney Injury with Hemoglobin Casts
por: Kora, Rishi, et al.
Publicado: (2018)

Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor
por: Escandon, Julia, et al.
Publicado: (2017)

Subclass Changes in Fibrillary Glomerulonephritis
por: Biederman, Laura E., et al.
Publicado: (2022)

Characterization of Glomerular Diseases Using Proteomic Analysis of Laser Capture Microdissected Glomeruli
por: Satoskar, AA, et al.
Publicado: (2012)

Acute glomerulonephritis with large confluent IgA-dominant deposits associated with liver cirrhosis
por: Hemminger, Jessica, et al.
Publicado: (2018)

PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
por: D'Incecco, A, et al.
Publicado: (2015)

Genomic Study on Blood Culture Isolates From Patients With Staphylococcus Infection-associated Glomerulonephritis
por: Rana, Pranav S.J.B., et al.
Publicado: (2022)

A Novel Humanized PD-1/PD-L1 Mouse Model Permits Direct Comparison of Antitumor Immunity Generated by Food and Drug Administration–Approved PD-1 and PD-L1 Inhibitors
por: Barham, Whitney, et al.
Publicado: (2023)

Role of protease‐activated receptor‐1 (PAR‐1) in the glomerular filtration barrier integrity
por: Medipally, Ajay, et al.
Publicado: (2022)

Ocular adverse events in PD-1 and PD-L1 inhibitors
por: Young, LeAnne, et al.
Publicado: (2021)

PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC
por: Del Re, Marzia, et al.
Publicado: (2018)

Kidney Biopsy Corner: Amyloidosis
por: Biederman, Laura E., et al.
Publicado: (2023)

Anticoagulant Related Nephropathy Only Partially Develops in C57BL/6 Mice: Hematuria Is Not Accompanied by Red Blood Cell Casts in the Kidney
por: Medipally, Ajay K., et al.
Publicado: (2021)

Differentiating Staphylococcus infection-associated glomerulonephritis and primary IgA nephropathy: a mass spectrometry-based exploratory study
por: Satoskar, Anjali A., et al.
Publicado: (2020)

Frequent PD-L1 expression in testicular germ cell tumors
por: Fankhauser, C D, et al.
Publicado: (2015)

Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases
por: Parakh, Sagun, et al.
Publicado: (2017)

Acute Tubular Necrosis and Interstitial Nephritis during Pemetrexed Therapy
por: Michels, Judith, et al.
Publicado: (2009)

Role of glomerular filtration rate‐modifying drugs in the development of anticoagulant‐related nephropathy
por: Medipally, Ajay K., et al.
Publicado: (2021)

Can Antinuclear Antibodies (ANA) be Monoclonal?
por: Biederman, Laura, et al.
Publicado: (2021)

Chronic Hematuria Increases Chronic Kidney Injury and Epithelial–Mesenchymal Transition in 5/6 Nephrectomy Rats
por: Xiao, Min, et al.
Publicado: (2021)

Renal Tubular Acidosis an Adverse Effect of PD-1 Inhibitor Immunotherapy
por: El Bitar, Sandy, et al.
Publicado: (2018)

Poor outcome with anti-programmed death-ligand 1 (PD-L1) antibody due to poor pharmacokinetic properties in PD-1/PD-L1 blockade-sensitive mouse models
por: Kurino, Taiki, et al.
Publicado: (2020)

Interstitial inflammation and interstitial fibrosis and tubular atrophy predict renal survival in lupus nephritis
por: Wilson, Parker C, et al.
Publicado: (2018)

CD4(+) T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy
por: Xiao, Minglu, et al.
Publicado: (2022)

Downregulation of PD-L1 via FKBP5 by celecoxib augments antitumor effects of PD-1 blockade in a malignant glioma model
por: Yamaguchi, Izumi, et al.
Publicado: (2019)

Obesity diminishes response to PD-1-based immunotherapies in renal cancer
por: Boi, Shannon K, et al.
Publicado: (2020)

Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
por: Kirby, Sean, et al.
Publicado: (2012)

Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesicles
por: Orme, Jacob J, et al.
Publicado: (2020)

PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer
por: Stein, Alexander, et al.
Publicado: (2021)

Inhibition of TCA cycle improves the anti-PD-1 immunotherapy efficacy in melanoma cells via ATF3-mediated PD-L1 expression and glycolysis
por: Liu, Nian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dt97aj7jkfdgkb2daqva7rt7k6